A Phase I, Open-Label, Multi-Center, Parallel Group Study to Assess the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients with and without Impaired Renal Function

  • Hayslip, John (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/6/1112/31/13